Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
| ▸ | CDC25C | P30307 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL100765 | 0.69 | HPGDS (0.46) | HPGDSLTA4H | |
| SCHEMBL1624105 | 0.69 | KMT2A (0.54) | KMT2APOLBRAB9AMEN1NPC1 | |
| SCHEMBL539177 | 0.69 | NOTUM (0.41) | KMT2APOLBRAB9AMEN1NPC1 | |
| SCHEMBL1429349 | 0.69 | KDM4A (0.39) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGDS | |
| SCHEMBL27360563 | 0.68 | HPGDS (0.37) | HPGDSLTA4H | |
| SCHEMBL2170537 | 0.67 | HPGDS (0.33) | HPGDSLTA4H | |
| SCHEMBL15600919 | 0.65 | KDM4A (0.43) | POLBRAB9ANPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL291210 | 0.65 | HPGDS (0.34) | HPGDSLTA4H | |
| SCHEMBL912864 | 0.65 | LTA4H (0.37) | HPGDSLTA4H | |
| SCHEMBL12571337 | 0.64 | HPGDS (0.41) | POLBRAB9ANPC1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102516268-B | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2014-08-13 | — | — | CN | claimed |
| WO-2012088431-A1 | FAAH INHIBITORS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2012-06-28 | — | — | WO | claimed |
| CN-102516268-A | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2012-06-27 | — | — | CN | claimed |
| US-7871982-B2 | Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient | MEIJI SEIKA KAISHA, LTD. (JP) | 2011-01-18 | — | — | US | claimed |
| US-20090156512-A1 | potent activity against resistant pneumococci | MEIJI SEIKA KAISHA, LTD. (JP) | 2009-06-18 | — | — | US | claimed |
| EP-1970377-A1 | LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | MEIJI SEIKA KAISHA LTD. (JP) | 2008-09-17 | — | — | EP | claimed |
| CN-112175012-A | Organic electroluminescent material and device | 环球展览公司 | 2021-01-05 | — | — | CN | disclosed |
| CN-102516268-B | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2014-08-13 | — | — | CN | disclosed |
| CN-102516268-B | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2014-08-13 | — | — | CN | disclosed |
| CN-102516268-B | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2014-08-13 | — | — | CN | disclosed |
| WO-2012088431-A1 | FAAH INHIBITORS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2012-06-28 | — | — | WO | disclosed |
| CN-102516268-A | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2012-06-27 | — | — | CN | disclosed |
| CN-102516268-A | Oxazole thiadiazole organic copper compound, its preparation method, preparation and application in controlling agricultural plant diseases | UNIV NORTHWEST A&F | 2012-06-27 | — | — | CN | disclosed |
| EP-1970377-A1 | LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | MEIJI SEIKA KAISHA LTD. (JP) | 2008-09-17 | — | — | EP | disclosed |
| US-7259157-B2 | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists | MERCK & CO., INC. (US) | 2007-08-21 | — | — | US | disclosed |
| US-20060258723-A1 | Substituted Heteroaryl- and Phenylsulfamoyl Compounds | PFIZER INC | 2006-11-16 | — | — | US | disclosed |
| CN-1763035-A | Oligothiophene-arylene derivatives and the OTFT of using it | SAMSUNG ELECTRONICS CO LTD (KR) | 2006-04-26 | — | — | CN | disclosed |
| US-20030119811-A1 | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists | MERCK SHARP & DOHME CORP. | 2003-06-26 | — | — | US | disclosed |
| US-5834468-A | ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS, ANALGESICS TREATING RHEUMATIC DISEASE, BONE DISORDER, INJURIES | ZENECA LIMITED (GB) | 1998-11-10 | — | — | US | disclosed |
| EP-0029934-A1 | Benzopyrano derivatives, pharmaceutical compositions containing them and processes for preparing the compounds and compositions | SCHERING CORPORATION (US) | 1981-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060258723-A1 | Substituted Heteroaryl- and Phenylsulfamoyl Compounds | PPARG, PPARA, PPARD | KMT2A 3601/4885POLB 2006/4885RAB9A 2063/4885 |
| US-20090156512-A1 | potent activity against resistant pneumococci | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NAT1, NPM1 | KMT2A 2133/4885POLB 2813/4885RAB9A 377/4885 |
| US-20030119811-A1 | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists | GRIN1, GRIN2B, GRIN2A | KMT2A 1148/4885POLB 4217/4885RAB9A 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.